FORM Wealth Advisors LLC bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,826 shares of the conglomerate's stock, valued at approximately $374,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $27,000. GHP Investment Advisors Inc. increased its stake in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares in the last quarter. Hurley Capital LLC acquired a new stake in Danaher in the fourth quarter worth about $34,000. Rialto Wealth Management LLC acquired a new stake in Danaher in the fourth quarter worth about $34,000. Finally, Dunhill Financial LLC increased its position in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Danaher
In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.
Wall Street Analyst Weigh In
DHR has been the subject of a number of research reports. Robert W. Baird lowered their price objective on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Wall Street Zen lowered Danaher from a "buy" rating to a "hold" rating in a research report on Monday, June 9th. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research report on Friday, March 14th. Leerink Partners lifted their price objective on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and an average price target of $248.17.
Check Out Our Latest Stock Report on DHR
Danaher Trading Up 0.0%
NYSE:DHR opened at $196.49 on Tuesday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05. The stock has a market capitalization of $140.62 billion, a PE ratio of 38.15, a price-to-earnings-growth ratio of 2.76 and a beta of 0.77. The business's 50-day simple moving average is $193.96 and its 200-day simple moving average is $209.14.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. Sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's payout ratio is 24.85%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.